Company / Operating Income
AMICUS THERAPEUTICS, INC. Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$32.8M
FY2025
5-year range
-$212.1M / $32.8M
FY2021-FY2025
Trend
+31.8%
vs FY2024
Sector context
#49 of 204
Health Care
What the data says
AMICUS THERAPEUTICS, INC.'s operating income of $33M is higher than 76% of companies in the Health Care sector (FY2025). Operating Income has increased for 3 consecutive years, from -$212M in FY2022 to $33M in FY2025.
Based on SEC 10-K filings.
$33M in FY2025. Top quartile in the Health Care sector.
Improved from -$77M to $33M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 24% in Health CareTop 24% of 204This company $32.8M Sector average $107.7M
▼
-69.6% below sector average
Key checks
Key Insights
- AMICUS THERAPEUTICS, INC.'s operating income has grown for 3 consecutive years.
- In FY2025, operating income increased 31.8% year-over-year.
- Ranks #49 out of 204 companies in the Health Care sector.
- Lowest operating income in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -1.19 (distress zone, below 1.8 threshold)
- Negative profit margin: -10.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $32.8M | +31.8% |
| FY2024 | $24.9M | +132.2% |
| FY2023 | -$77.2M | +63.6% |
| FY2022 | -$212.1M | -2.8% |
| FY2021 | -$206.4M | +16.4% |
| FY2020 | -$247.0M | +18.8% |
| FY2019 | -$304.0M | +7.5% |
| FY2018 | -$328.8M | +25.6% |
| FY2017 | -$442.0M | -143.0% |
| FY2016 | -$181.9M | -39.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026